Virios Therapeutics, Inc. (VIRI)
NASDAQ: VIRI · Real-Time Price · USD
0.211
+0.001 (0.43%)
At close: Aug 23, 2024, 4:00 PM
0.206
-0.005 (-2.38%)
After-hours: Aug 23, 2024, 7:45 PM EDT
Virios Therapeutics Employees
Virios Therapeutics had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,169,854
Market Cap
5.84M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | 0 | - |
Dec 31, 2022 | 4 | -1 | -20.00% |
Dec 31, 2021 | 5 | 2 | 66.67% |
Dec 31, 2020 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Telesis Bio | 147 |
IM Cannabis | 95 |
MSP Recovery | 88 |
Windtree Therapeutics | 20 |
BioCardia | 20 |
Innovative Eyewear | 11 |
Adial Pharmaceuticals | 7 |
Xenetic Biosciences | 4 |
VIRI News
- 16 days ago - Virios Therapeutics Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 23 days ago - Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewsWire
- 4 weeks ago - Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center - GlobeNewsWire
- 3 months ago - Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study - GlobeNewsWire
- 3 months ago - Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study - GlobeNewsWire
- 3 months ago - Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study - GlobeNewsWire
- 3 months ago - Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire